anmelden
NYSE US 100
18.560,15
PKT
+116,56
PKT
+0,63
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE US 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.02.11 | ExxonMobil outperform | Oppenheimer & Co. Inc. | |
| 03.02.11 | FedEx outperform | Robert W. Baird & Co. Incorporated | |
| 03.02.11 | AT&T outperform | Credit Suisse Group | |
| 03.02.11 | Marathon Oil outperform | Credit Suisse Group | |
| 03.02.11 | AT&T equal-weight | Barclays Capital | |
| 03.02.11 | Emerson Electric overweight | Barclays Capital | |
| 03.02.11 | Pfizer overweight | Barclays Capital | |
| 02.02.11 | Emerson Electric perform | Oppenheimer & Co. Inc. | |
| 03.02.11 | AT&T outperform | Barrington Research | |
| 03.02.11 | United Parcel Service overweight | Barclays Capital | |
| 02.02.11 | United Parcel Service outperform | RBC Capital Markets | |
| 02.02.11 | Walt Disney overweight | Barclays Capital | |
| 02.02.11 | ExxonMobil halten | Independent Research GmbH | |
| 03.02.11 | Pfizer halten | Independent Research GmbH | |
| 03.02.11 | United Parcel Service neutral | Credit Suisse Group | |
| 01.02.11 | Valero Energy outperform | Oppenheimer & Co. Inc. | |
| 01.02.11 | ExxonMobil neutral | UBS AG | |
| 02.02.11 | ExxonMobil neutral | Credit Suisse Group | |
| 01.02.11 | U.S. Bancorp overweight | Barclays Capital | |
| 01.02.11 | Honeywell overweight | Barclays Capital | |
| 01.02.11 | Corning overweight | Barclays Capital | |
| 01.02.11 | PepsiCo overweight | Barclays Capital | |
| 02.02.11 | United Parcel Service outperform | Morgan Keegan & Co., Inc. | |
| 01.02.11 | Citigroup equal-weight | Morgan Stanley | |
| 31.01.11 | Emerson Electric outperform | Credit Suisse Group | |
| 31.01.11 | Chevron outperform | Credit Suisse Group | |
| 02.02.11 | Coca-Cola kaufen | Hamburger Sparkasse AG (Haspa) | |
| 31.01.11 | Honeywell outperform | RBC Capital Markets | |
| 31.01.11 | Honeywell outperform | Oppenheimer & Co. Inc. | |
| 31.01.11 | Procter Gamble halten | Independent Research GmbH | |
| 01.02.11 | Chevron overweight | Barclays Capital | |
| 31.01.11 | Eli Lilly equal-weight | Barclays Capital | |
| 31.01.11 | Chevron halten | Independent Research GmbH | |
| 31.01.11 | Bristol-Myers Squibb overweight | Barclays Capital | |
| 31.01.11 | Baxter International equal-weight | Barclays Capital | |
| 31.01.11 | JPMorgan Chase overweight | Barclays Capital | |
| 31.01.11 | Franklin Resources overweight | Barclays Capital | |
| 31.01.11 | Altria equal-weight | Barclays Capital | |
| 28.01.11 | Procter Gamble outperform | Credit Suisse Group | |
| 28.01.11 | Colgate-Palmolive neutral | Credit Suisse Group |